Van Woensel, M.; Wauthoz, N.; Rosière, R.; Amighi, K.; Mathieu, V.; Lefranc, F.; Van Gool, S.W.; De Vleeschouwer, S.
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? Cancers 2013, 5, 1020-1048.
https://doi.org/10.3390/cancers5031020
AMA Style
Van Woensel M, Wauthoz N, Rosière R, Amighi K, Mathieu V, Lefranc F, Van Gool SW, De Vleeschouwer S.
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? Cancers. 2013; 5(3):1020-1048.
https://doi.org/10.3390/cancers5031020
Chicago/Turabian Style
Van Woensel, Matthias, Nathalie Wauthoz, Rémi Rosière, Karim Amighi, Véronique Mathieu, Florence Lefranc, Stefaan W. Van Gool, and Steven De Vleeschouwer.
2013. "Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?" Cancers 5, no. 3: 1020-1048.
https://doi.org/10.3390/cancers5031020
APA Style
Van Woensel, M., Wauthoz, N., Rosière, R., Amighi, K., Mathieu, V., Lefranc, F., Van Gool, S. W., & De Vleeschouwer, S.
(2013). Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? Cancers, 5(3), 1020-1048.
https://doi.org/10.3390/cancers5031020